← Earnings Calendar
Coverage News Earnings Hub Grades Earnings Report
RLMD Q3 2026
Relmada Therapeutics Inc
Pharmaceuticals
—
No Grade
🚀
Strong Beat
Actual $-0.11 vs Est $-0.20
+45.9%
📊 EPS Scorecard
EPS Estimate
$-0.20
EPS Actual
$-0.11
Surprise
+45.9%
Period2026-06-30
QuarterQ3 2026
📈 EPS Momentum — Last 4 Quarters
$-0.30
25-09
$-0.29
25-12
$-0.22
26-03
$-0.11
26-06
📈 +63% over 4 quarters
🤖 ESEN AI Grade Reasoning
🔒 AI Grade Reasoning Unlock with PLUS
🔗 Other RLMD Earnings
RLMD
Q1 2026
→ View
RLMD
Q2 2026
→ View
RLMD
Q4 2026
→ View
RLMD
Full Research
→ Stock Page
Unlock Full Earnings Analysis
AI grade reasoning, momentum alerts, and full analysis for 5,000+ stocks
Start PLUS — First Month $4.99
Then $19.99/month · Cancel anytime